SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 200 filers reported holding SAGE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $276,000 | -48.8% | 3,200 | -83.0% | 0.23% | -20.3% |
| Q1 2020 | $539,000 | -89.4% | 18,800 | -32.6% | 0.29% | -19.2% |
| Q2 2019 | $5,108,000 | +248.7% | 27,900 | +82.4% | 0.35% | +250.5% |
| Q4 2018 | $1,465,000 | +48.3% | 15,300 | +118.6% | 0.10% | +77.2% |
| Q3 2018 | $988,000 | -77.3% | 7,000 | -90.0% | 0.06% | -75.5% |
| Q3 2017 | $4,354,000 | -21.8% | 69,900 | 0.0% | 0.23% | -32.1% |
| Q2 2017 | $5,566,000 | +36.2% | 69,900 | +21.6% | 0.34% | +32.9% |
| Q1 2017 | $4,086,000 | +1031.9% | 57,500 | +379.2% | 0.26% | +658.8% |
| Q2 2016 | $361,000 | -82.8% | 12,000 | -81.7% | 0.03% | -84.0% |
| Q1 2016 | $2,099,000 | +443.8% | 65,500 | +750.6% | 0.21% | +292.6% |
| Q1 2015 | $386,000 | +57.6% | 7,700 | +14.9% | 0.05% | +31.7% |
| Q4 2014 | $245,000 | – | 6,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |